Cargando…
Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
BACKGROUND: To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. METHODS: A prospective observational study was conduc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240212/ https://www.ncbi.nlm.nih.gov/pubmed/30445969 http://dx.doi.org/10.1186/s12967-018-1687-0 |
_version_ | 1783371596851838976 |
---|---|
author | Yang, Xiaoxiao Zhang, He Shi, Yuanyuan Yu, Zanzhe Yan, Hao Ni, Zhaohui Qian, Jiaqi Fang, Wei |
author_facet | Yang, Xiaoxiao Zhang, He Shi, Yuanyuan Yu, Zanzhe Yan, Hao Ni, Zhaohui Qian, Jiaqi Fang, Wei |
author_sort | Yang, Xiaoxiao |
collection | PubMed |
description | BACKGROUND: To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. METHODS: A prospective observational study was conducted in 324 chronic PD patients. Biochemical analysis was performed at baseline for serum angiopoietins, albumin and high sensitive C-reactive protein (hs-CRP) and echocardiography was done to detect cardiac valvular calcification. Primary study end points were fatal or nonfatal cardiovascular events and mortality. RESULTS: The median of serum Angpt-2 levels was 5.44 ng/mL (interquartile range, 3.41–7.85). Across the three tertiles of serum Angpt-2, a significant trend effect was observed for body mass index, normalized protein catabolic rate, calcium × phosphorus product, hs-CRP, brain natriuretic peptide, lower-density lipoprotein cholesterol, left ventricular ejection fraction, total weekly urea clearance and residual renal function (all p < 0.05). Serum Angpt-2 showed a significant increase across the four groups of patients with increasing components of MIAC syndrome (p < 0.001). There were 77 deaths and 57 cardiovascular events. High serum Angpt-2 was an independent predictor of fatal and nonfatal cardiovascular events in PD patients (p = 0.02), however serum Angpt-2 was not an independent predictor of all-cause mortality (p = 0.3). CONCLUSIONS: Serum Angpt-2 showed close association with valvular calcification, atherosclerosis, inflammation and malnutrition, having significant independent prognostic value and is useful for cardiovascular event stratification in chronic PD patients. Angpt-2 might be a potential mediator of increased cardiovascular risk in patients undergoing PD treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1687-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6240212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62402122018-11-26 Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study Yang, Xiaoxiao Zhang, He Shi, Yuanyuan Yu, Zanzhe Yan, Hao Ni, Zhaohui Qian, Jiaqi Fang, Wei J Transl Med Research BACKGROUND: To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. METHODS: A prospective observational study was conducted in 324 chronic PD patients. Biochemical analysis was performed at baseline for serum angiopoietins, albumin and high sensitive C-reactive protein (hs-CRP) and echocardiography was done to detect cardiac valvular calcification. Primary study end points were fatal or nonfatal cardiovascular events and mortality. RESULTS: The median of serum Angpt-2 levels was 5.44 ng/mL (interquartile range, 3.41–7.85). Across the three tertiles of serum Angpt-2, a significant trend effect was observed for body mass index, normalized protein catabolic rate, calcium × phosphorus product, hs-CRP, brain natriuretic peptide, lower-density lipoprotein cholesterol, left ventricular ejection fraction, total weekly urea clearance and residual renal function (all p < 0.05). Serum Angpt-2 showed a significant increase across the four groups of patients with increasing components of MIAC syndrome (p < 0.001). There were 77 deaths and 57 cardiovascular events. High serum Angpt-2 was an independent predictor of fatal and nonfatal cardiovascular events in PD patients (p = 0.02), however serum Angpt-2 was not an independent predictor of all-cause mortality (p = 0.3). CONCLUSIONS: Serum Angpt-2 showed close association with valvular calcification, atherosclerosis, inflammation and malnutrition, having significant independent prognostic value and is useful for cardiovascular event stratification in chronic PD patients. Angpt-2 might be a potential mediator of increased cardiovascular risk in patients undergoing PD treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1687-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-16 /pmc/articles/PMC6240212/ /pubmed/30445969 http://dx.doi.org/10.1186/s12967-018-1687-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Yang, Xiaoxiao Zhang, He Shi, Yuanyuan Yu, Zanzhe Yan, Hao Ni, Zhaohui Qian, Jiaqi Fang, Wei Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study |
title | Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study |
title_full | Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study |
title_fullStr | Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study |
title_full_unstemmed | Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study |
title_short | Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study |
title_sort | association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240212/ https://www.ncbi.nlm.nih.gov/pubmed/30445969 http://dx.doi.org/10.1186/s12967-018-1687-0 |
work_keys_str_mv | AT yangxiaoxiao associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy AT zhanghe associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy AT shiyuanyuan associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy AT yuzanzhe associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy AT yanhao associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy AT nizhaohui associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy AT qianjiaqi associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy AT fangwei associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy |